Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate
- 31 August 2001
- journal article
- Published by Elsevier in Seminars in Oncology
- Vol. 28, 8-15
- https://doi.org/10.1016/s0093-7754(01)90149-6